Medacy is CHASE’s sister company and specialist clinical pharmacist services provider. Where CHASE connects life sciences organisations with the people and partnerships they need, Medacy works directly inside the NHS, deploying fully managed teams of clinical pharmacists into GP practices, PCNs, ICBs and hospital trusts across England.
With over 60 permanently employed pharmacists delivering more than 500,000 patient interactions every year, Medacy is one of the UK’s most established providers of pharmacist-led clinical services. This on-the-ground NHS presence is what makes the wider CHASE patient services so distinctive.
Medacy’s model is built around permanently employed, fully managed clinical pharmacists, not locums. Every pharmacist is employed directly by Medacy, supported by an expert clinical network, and deployed where the NHS needs them most.Services operate across two models: fully managed on-site pharmacist services for practices and PCNs, and remote clinical pharmacist services for organisations that need flexibility without sacrificing clinical depth.
Permanently employed Medacy pharmacists embedded in GP practices and PCNs, taking the lead on medicines management, structured medication reviews, long-term condition monitoring and prescribing support. Reduces GP workload and improves patient safety.
Flexible remote pharmacist support for practices and PCNs that need clinical capacity without the overhead of an on-site placement. Medacy’s remote pharmacists engage patients directly, supporting adherence, medication queries and medicines optimisation.
Specialist clinical pharmacist-led therapy reviews going beyond standard medication reviews. Focusing on disease-specific protocols, monitoring requirements and shared care arrangements for patients on complex or high-risk medicines such as DMARDs and biologics.
Tailored clinical pharmacist programmes designed with NHS commissioners and clinical leads to address specific population health priorities, from DMARD monitoring and medicines optimisation to condition-specific care pathway redesign.
Business analysis, process review and staff training for dispensing GP practices, helping them improve efficiency, prescribing quality and financial performance.
Permanent, locum and specialist clinical pharmacist recruitment for NHS organisations that need to build or supplement their own pharmacy teams.
Medacy works with NHS organisations across primary, community and integrated care, tailoring its services to the specific needs and pressures of each setting.
Reducing GP workload, improving prescribing quality and patient safety
Driving medicines optimisation and population health improvement across the network
System-level medicines optimisation and population health programmes
Community-based services aligned with the NHS 10-Year Plan shift to neighbourhood care
The challenge
Patients with inflammatory arthritis managed on Disease-Modifying Anti-Rheumatic Drugs (DMARDs) require regular blood test monitoring to ensure safe, continued use. Traditionally managed in secondary care, this created bottlenecks: as many as two thirds of rheumatology outpatient appointments were for monitoring only, creating long waiting lists and inefficient use of consultant time. Patients who were stable were attending hospital unnecessarily, while new patients waited longer for access.
Our solution
Medacy piloted a community-based DMARD monitoring service in North Buckinghamshire, with specialist clinical pharmacists based in primary care taking over monitoring responsibilities for stable patients. Working alongside secondary care consultants and aligned with the NHS Long Term Plan’s focus on out-of-hospital care, pharmacists ensured timely blood tests, acted on abnormalities, followed up missed tests and provided direct patient counselling on therapy adherence. During the COVID-19 pandemic, the model proved particularly resilient — pharmacists built a centralised data system to identify and prioritise all high-risk patients during the outbreak.
58% to <1% - Reduction in patients without an active shared care agreement
52% to 94% - Increase in blood test protocol adherence
42% of at-risk patients safeguarded by timely intervention
131 additional patients identified as eligible for monitoring, many previously lost to follow-up
“Having a pharmacist working within the practice has decreased the workload for GPs and improved the safety and quality of our prescribing.”
Dr Stephanie Merrifield
“Medacy’s expertise, proactive approach, and collaborative attitude have had a tangible impact on our PCN. Their support and involvement have been highly valued by both practice teams and the wider PCN, helping drive innovation and improved patient outcomes.”
Trent Care
“Beyond fulfilling DES requirements, Medacy are contributing significantly to PCN development projects. A key example is their central role in initiating and supporting our pain medication management project, a collaborative initiative across the PCN workforce.”
Grace Bowker
Medacy’s permanent clinical presence inside the NHS is what gives CHASE its real-world clinical grounding. When CHASE designs an NHS-Industry partnership, runs a patient programme or delivers insights for a life sciences client, it is Medacy’s pharmacists, working in practices and PCNs every day, who provide the clinical intelligence, patient access and NHS relationships that make those services work.
For life sciences companies working with CHASE, that means access to a genuinely embedded NHS clinical network. Not just a directory of contacts, but pharmacists who are already trusted by the practices, PCNs and commissioners they work with.
Find out more about Medacy
Medacy has its own dedicated website with full details of its clinical pharmacistservices, NHS support and how to work with them.
Visit the Medacy website for the full picture or get in touch with the CHASE team.
.svg)
